HLA Q1区

期刊简介

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

HLA出版完整的原创文章、简短的通讯、评论和评论，涵盖免疫遗传控制的所有方面。范围包括对免疫系统分子的功能、生化和遗传学研究，包括细胞表面受体及其配体，并包括细胞因子、趋化因子、粘附和共刺激分子、抗原受体（如TcR、NKR、CD1、PAMPs、Igs、KIR）和主要组织相容性复合体的基因和产物（包括经典和非经典HLA分子）。论文应描述在体外或动物模型中的原创性研究，或反映实体器官或造血干细胞移植、自身免疫、感染免疫、过敏、肿瘤免疫、疫苗科学、妊娠和疾病易感性的免疫遗传学的临床研究。

《HLA》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： Primary Care Diabetes
• 下一篇：INTERNATIONAL AFFAIRS